NovoCure Ltd (NVCR)
12.64
+0.41
(+3.35%)
USD |
NASDAQ |
Apr 26, 16:00
12.64
0.00 (0.00%)
After-Hours: 17:11
NovoCure Cash from Investing (TTM): 184.15M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 184.15M |
| September 30, 2023 | -42.41M |
| June 30, 2023 | -209.91M |
| March 31, 2023 | -40.26M |
| December 31, 2022 | -139.96M |
| September 30, 2022 | -510.99M |
| June 30, 2022 | -58.04M |
| March 31, 2022 | -216.42M |
| December 31, 2021 | -144.83M |
| September 30, 2021 | -259.38M |
| June 30, 2021 | -414.87M |
| March 31, 2021 | -415.56M |
| December 31, 2020 | -472.85M |
| September 30, 2020 | 94.04M |
| June 30, 2020 | -55.36M |
| March 31, 2020 | -53.79M |
| December 31, 2019 | -51.67M |
| Date | Value |
|---|---|
| September 30, 2019 | -6.70M |
| June 30, 2019 | -5.531M |
| March 31, 2019 | -4.625M |
| December 31, 2018 | -5.493M |
| September 30, 2018 | -5.65M |
| June 30, 2018 | -6.398M |
| March 31, 2018 | -6.142M |
| December 31, 2017 | 8.628M |
| September 30, 2017 | 7.164M |
| June 30, 2017 | 4.503M |
| March 31, 2017 | -1.536M |
| December 31, 2016 | 13.00M |
| September 30, 2016 | -109.63M |
| June 30, 2016 | -77.85M |
| March 31, 2016 | -109.13M |
| December 31, 2015 | -115.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-510.99M
Minimum
Sep 2022
184.15M
Maximum
Dec 2023
-148.44M
Average
-58.04M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| AtriCure Inc | 21.82M |
| NeuroMetrix Inc | 1.156M |
| Repligen Corp | -123.28M |
| Teleflex Inc | -621.23M |
| Perspective Therapeutics Inc | 24.37M |